CD109 and squamous cell carcinoma: However, as a co-receptor of the transforming growth factor (TGF)-β receptor (TGF-βR) [14,15,16], CD109 was reported to negatively regulate the epithelial-to-mesenchymal transition (EMT) by antagonizing TGF-β signaling in squamous cell carcinomas [17].